Evotec Stock
WKN 566480 | ISIN DE0005664809

Quote

  Bid Ask
Quote 17,675 17,68
Units 307 Units 283 Units
current/rel. spread 0,005 0,0283%
Quote time 23/07/2018 12:01:58
Daily high/low (money) 17,82 17,10
Change compared with
previous day (bid)
0,415 +2,40%

Price data

Stock exchange Stuttgart  
Last 17,755G 0 Units
Price determination time 23/07/2018 11:45:07
Daily volume (Units) 15.393  
Daily high/low 17,825 17,225
Prev. day's price (20/07) 17,27  
Change day before +0,49 +2,81%
Yearly high/low 17,48 (20/07) 12,10 (10/05)
52 week high / low 22,58 (04/10) 11,40 (25/07)

Latest quotes

Quote time Bid Ask
23/07/2018 / 12:01:58 17,675 17,68
23/07/2018 / 12:01:56 17,67 17,68
23/07/2018 / 12:01:55 17,67 17,68
23/07/2018 / 12:01:55 17,67 17,68
23/07/2018 / 12:01:45 17,67 17,68
23/07/2018 / 12:01:44 17,67 17,675
Historical quotes on Evotec

Key performance figures

  1 week 1 month 3 months 1 year 3 years 5 years
Performance +9,13% +14,67% +19,31% +42,85% +406,45% +574,35%
Rel. performance onEurostoxx 50 +9,23% +14,92% +21,74% +45,39% +414,31% +548,59%
Rel. performance onTecDAX +7,43% +13,82% +11,04% +18,65% +350,69% +385,76%

Video

Evotec Key figures

  2018e 2017 2016 2015
PER 56,50 79,41 37,21 32,08
Earnings per share 0,31 0,17 0,20 0,13
Dividend 0,00 0,00 0,00 0,00
Dividend yield in % 0,00 0,00 0,00 0,00

Additional key figures on Evotec

Evotec Master data

WKN 566480
ISIN DE0005664809
Symbol EVT
Exchange segment Open Market
Type of financial instrument Stock
Denomination EVOTEC
Index membership CDAX KURSINDEX TecDAX
Trading segment -
Trading hours 8:00 - 22:00 Uhr
Trading currency EUR
Nominal currency EUR
Settlement currency EUR
Sector and industry Chemical/Pharmaceutical/Health - Biotechnology
Number of shares 147.533.000
Market capitalisation 2,54 Mrd.

Evotec Peer group

Name WKN Price Change / previous day
FLUIDIGM CORP A0RADJ 5,44 +14,77%
GTX INC. A2DHVY 13,99 +12,46%
NEOTHETICS INC A2JBZC 2,14 +10,88%
ORIGIN AGRITECH LTD. A2NB42 8,78 +10,44%
SIRONA BIOCHEM CORP A0RM6R 0,047 +9,30%
AC IMMUNE SA A2AR5F 13,34 +9,09%

Evotec Corporate events

Date Corporate event
No entries found

Evotec in the profile

Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. We operate worldwide providing the highest quality stand-alone and integrated drug discovery solutions, covering all activities from target-to-clinic. The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuroscience, pain, metabolic diseases as well as oncology, inflammation and infectious diseases. Evotec has long-term discovery alliances with partners including Bayer, Boehringer Ingelheim, CHDI, Genentech, Janssen Pharmaceuticals, MedImmune/AstraZeneca, Roche and UCB. In addition, the Company has existing development partnerships and product candidates both in clinical and..

More information about Evotec can be found in the profile